Cargando…
Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option?: Comment
This is a comment on the low prevalence of smokers in hospitalized COVID-19 patients, citing the possible role of squamous cell metaplasia, which is commonly associated with smokers.
Autor principal: | Rajput, Dinesh Vijay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7279633/ https://www.ncbi.nlm.nih.gov/pubmed/32514683 http://dx.doi.org/10.1007/s11739-020-02396-y |
Ejemplares similares
-
Systematic review of the prevalence of current smoking among hospitalized COVID‑19 patients in China: could nicotine be a therapeutic option?
por: Takagi, Hisato
Publicado: (2020) -
Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option? Reply
por: Farsalinos, Konstantinos, et al.
Publicado: (2020) -
Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option?
por: Farsalinos, Konstantinos, et al.
Publicado: (2020) -
COVID-19: counter-intuitive data on smoking prevalence and therapeutic implications for nicotine
por: Polosa, Riccardo, et al.
Publicado: (2020) -
Clinical risk scores for the early prediction of severe outocomes in patients hospitalized for COVID-19: comment
por: Rossio, Raffaella, et al.
Publicado: (2021)